Connect with us

Politics

Vermont Bill To Legalize Marijuana Sales Moves To House

Published

on

As Vermont’s legislature resumes following last week’s recess, key committees and lawmakers are putting renewed focus on legislation to tax and regulate marijuana sales for adults.

The state Senate gave veto-proof approval to S. 54 earlier this month. Now the proposal goes to the House for consideration, but the larger legislative body isn’t going to rush into a floor vote right away; it still has other bills to evaluate before it can take up legislation “crossing over” from the Senate.

“The House has a tendency to go through things with a fine-tooth comb,” Rep. Sam Young (D) of Glover told Marijuana Moment in an interview. “It’s just the nature of the House. We’ve never taken testimony on tax and regulate either.”

“The Senate’s done it several times, but not in the House,” he said. “I believe the support is there, we’ve just got to do the work and fine-tune some stuff.”

The Senate-passed legislation would impose a 16 percent excise tax on sales along with a two percent local option tax for towns that levee the fee. The bill provides for the creation of a three-person Cannabis Control Board that would issue licenses and regulate the marijuana economy. Officials have projected a range of $3.8 million to $7.4 million in revenue in the first fiscal year, with the expected haul rising to as much as $16.6 million by 2024.

The bill has not yet been assigned to a committee by House Speaker Mitzi Johnson (D), though Rep. Sarah Copeland-Hanzas (D) of Bradford said it is likely to come before the House Committee on Government Operations, which she chairs.

“It could reside in my committee the entire time and I could ask for input from the Judiciary, Agriculture, General and probably the Human Services committees as well,” she said.

Copeland-Hanzas said she’ll also likely end up needing additional panels to consult on the bill.

Under the legislation as it stands, licenses for cultivators and testing labs would be issued between September and October of 2020. Retailers would receive licenses in spring 2021.

Vermont became the first state to legalize marijuana by legislative action—as opposed to via a voter initiative—in 2018, but it left out any provision to allow its sale. The Senate has passed legislation to legalize and regulate cannabis sales multiple times in the past, but the larger House, where S. 54 sits now, has failed to adopt similar proposals.

While the current bill’s path through the House remains to be seen, proponents say newly expanded Democratic and Progressive majorities in both chambers will play to their favor.

“The fact that we have separated the question of whether or not we have marijuana legal for adult consumption from the question of whether or not we have retail sales does make a difference to a lot of people,” Copeland-Hanzas said.

Dave Silberman, an attorney and pro bono drug policy reform advocate from Middlebury, said he was looking forward to hearing testimony in the House.

“My sense is the reason that tax and regulate votes have failed in the House in the past is because there have been no substantive committee hearings on tax and regulate,” he said. “In order to get big policy done, a lot of people just feel like the process is very important and folks who are sympathetic toward tax and regulate, who are supportive of tax and regulate, have held back because of that lack of process.”

“What’s different this year is that the speaker has publicly stated that we are going to get multiple committees involved with the process this year, and I think that’s a huge step this year,” he added. “It’s something I’ve been begging for for the past three years.”

Although she has committed to holding hearings on the issue, House Speaker Mitzi Johnson (D) has also said she’s unconvinced the state is ready for taxed and regulated sales.

“You know, I’m honestly really torn on it,” she told Vermont Public Radio in January.

The House’s Committee on General, Housing and Military Affairs is holding on to H. 196, a separate tax and regulate bill, authored and introduced by Young and cosponsored by more than a third of the House’s membership. In his legislation, existing dispensaries, which currently only serve patients on the state’s medical marijuana registry, could pay a $75,000 fee to start recreational sales to the public next year.

Those collected funds would be used to offset the costs of setting up the Cannabis Control Board. Senate leaders opted to not include a similar measure in their bill, saying it would create an unfair advantage for the current providers.

“I think it could be helpful in front-loading some of the revenue that we need,” Copeland-Hanzas said. “This is really all about consumer protection, and it’s hard to imagine where in a small state we’re going to find a bunch of budgetary dollars to do that.”

Other details the House will have to grapple with include the rate at which sales are taxed, funds for education and prevention efforts and the number of positions on the Cannabis Control Board— which had dropped from five to three positions in the final version of the Senate’s bill.

Gov. Phil Scott (R), who reluctantly signed legislation to legalize low-level marijuana possession and home cultivation last year, has said he would be unwilling to sign a bill to tax and regulate sales unless public safety initiatives, including roadside testing, are funded as well.

“To be very direct: There must be comprehensive and convincing plans completed in these areas before I will begin to consider the wisdom of implementing a commercial ‘tax and regulate’ system for an adult marijuana market,” he said last year prior to signing the previous bill.

Young said he’s aware of Scott’s demands.

“We need to work it out with the governor because we’re going to need a signature,” he said. “Without it, all the effort is for nothing.”

Vermont Senate Passes Marijuana Sales Legalization Bill

Photo courtesy of Philip Steffan.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Politics

GOP Congressman Falsely Claims Marijuana Can Be Legally Consumed In Public In ‘Many States’

Published

on

A Republican congressman wrongly claimed that marijuana can be legally consumed in public in “many states” in a Twitter post on Friday.

Following a House vote in favor of anti-vaping legislation that also included a ban on menthol cigarettes, Rep. Andy Barr (R-KY) argued that the bill is an example of government overreach and that it would not prevent youth from using vaping products.

“Now, Democrats propose making possession of a menthol cigarette a violation of federal law when smoking a marijuana joint in public is legal in many states,” he wrote in his tweet. “Instead, we need to focus on real healthcare issues like surprise billing, the opioid epidemic and curbing coronavirus.”

The claim about laws governing public cannabis consumption is likely to raise eyebrows among reform advocates familiar with state-legal marijuana programs.

It’s not the case that “many states” allow individuals to smoke in public areas. In fact, it’s one of the most commonly prohibited activities in legalization measures.

“Rep. Barr is anti-freedom and pro-false hysteria when it comes to cannabis,” Justin Strekal, political director of NORML, told Marijuana Moment. “Sadly, his desire to continue to see hundreds of thousands of Americans be arrested and incarcerated due to minor marijuana charges is held far too many of his colleagues in Congress.”

Karen O’Keefe, director of state policies at the Marijuana Policy Project, told Marijuana Moment that Barr’s “facts and priorities are wrong.”

“No legalization state allows public smoking of cannabis (other than in adult-only locations in some cases), and almost all medical cannabis states forbid it,” she said. “Marijuana isn’t associated with increased mortality, while cigarettes are associated with more than 480,000 deaths a year in the U.S. alone. Why is Rep. Barr maligning and voting against the safer substance, and working to keep it illegal?”

Here are some examples of public consumption policies in legal cannabis states.

Alaska: For adults over 21 years of age, the law permits “consumption of marijuana, except that nothing in this chapter shall permit the consumption of marijuana in public.”

California: “You can consume cannabis on private property but you cannot consume, smoke, eat, or vape cannabis in public places.”

Colorado: “Using marijuana in any way—smoking, eating or vaping—isn’t allowed in public places.”

Illinois: “There is no public consumption allowed for cannabis. Smoking or consuming weed is illegal in motor vehicles and public spaces, including your front porch.”

Massachusetts: “You can’t use marijuana in any form (smoking, vaping, edibles, etc.) in public or on federal land.”

Nevada: “Adults 21 years and older can legally consume marijuana, but with restrictions on where it can be consumed: You cannot use marijuana in any public place.”

Oregon: “Recreational marijuana cannot be sold or smoked in public.”

Put simply, the notion that public consumption of marijuana is widespread is a false narrative. A standout exception is Oklahoma, where medical cannabis patients are able to consume wherever tobacco is permitted. That said, Barr’s assertion that public marijuana smoking is legal in “many states” is patently false.

That the congressman is perpetuating that narrative isn’t especially surprising, however. Barr is no fan on cannabis, voting against spending bill amendments preventing the Justice Department from using its fund to interfere in state-legal medical marijuana programs as well as a separate measure last year that would’ve extended protections to all state cannabis programs.

That said, Barr isn’t alone in his opposition to the menthol cigarette ban that cleared the House on Friday. Several Democrats joined Republicans in voting against the measure in committee and on the floor. But their reasoning was generally that the targeted ban would lead to overpolicing of minority communities.

House Democrats Block Amendment To Restrict Marijuana Products In Anti-Vaping Bill

Photo courtesy of WeedPornDaily.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

VA Notice About Researching Medical Marijuana For Military Veterans Deleted Shortly After Posting

Published

on

The U.S. Department of Veterans Affairs (VA) will soon release a notice announcing that it is seeking information about the potential of marijuana and its components to treat medical conditions that commonly afflict military veterans.

A post describing the request was briefly uploaded to a government website this week, though it’s since been deleted—but not before Marijuana Moment downloaded a copy. A representative said in response to an e-mailed query that the document was “rescinded for edits” and a revised version will be published “at a future date.”

VA’s Clinical Science Research and Development Service wrote in the filing that it is interested in establishing a research program designed to “examine the potential for medical marijuana and cannabinoids to treat disorders and diseases prevalent in our Veteran population.”

In a request for white papers on the topic, the department said it’s especially interested in identifying potential medical uses for cannabis to treat neuropathic pain and symptoms of post-traumatic stress disorder (PTSD).

“Unrelieved neuropathic pain experienced by Veterans after spinal cord or peripheral nerve injury contributes to depression, anxiety, disrupted sleep, and overall decreased quality of life,” VA said. “PTSD, also highly prevalent in Veterans, is a mental health problem often co-morbid with chronic pain.”

“A large percentage of Veterans who seek relief from these conditions, resort to smoking marijuana or use unregulated dietary cannabis supplements, etc,” it continued. “It is therefore imperative to determine which cannabinoid compounds are truly effective, for which symptoms, in which populations, as well as the associated risks.”

VA said it is committed to researching and developing evidence-based treatment options for veterans, and that’s what the program is meant to address.

“Without the needed evidence base for medical marijuana, this will not be a treatment choice within VA,” the department wrote. “We hope to support a series of clinical trials, which in case of positive outcomes, will generate robust data to support the use of cannabinoid(s) for pain and/or PTSD (or one or more of its symptoms).”

The department plans to conduct clinical trials if the evidence indicates that medical cannabis can be useful. It touted the “cadre of experienced clinical investigators, a highly participatory research population, and mechanisms in place to support every aspect of clinical research.”

White papers submitted to VA under the now-deleted solicitation must contain four components: 1) the “formulation and route of administration of the cannabinoid preparation,” 2) their ability to manufacture and supply those preparations, 3) the investigational new drug registration for compounds that aren’t already approved by the Food and Drug Administration (FDA) and 4) evidence about the product’s efficacy in treating pain, PTSD and other conditions.

As drafted, the notice gives a deadline of March 15 to submit the requested one-page white papers, though it’s not clear if that will change when the updated notice is released.

Additionally, VA said it plans to collaborate with industry partners for “further understanding and development of evidence-based treatments such as medical marijuana and cannabinoids” and on April 27, will hold an “Industry Day” to discuss the “goals of the program.”

The department is “particularly interested in obtaining information about cannabinoid drugs availability, likelihood of their approval by the FDA (if not yet approved), and the data supporting their use for pain and PTSD treatment in Veterans,” the notice says.

Members of Congress and veterans advocates discussed the need for alternative treatment options, including medical cannabis, during a joint committee hearing earlier this week.

At the same time, bipartisan legislators are asking their colleagues to cosponsor a bill that would require VA to conduct research into the therapeutic potential of marijuana for veterans. That legislation already has 104 House cosponsors.

Read VA’s since-rescinded notice on medical marijuana research below: 

VA Request For Medical Mari… by Marijuana Moment on Scribd

House Democrats Block Amendment To Restrict Marijuana Products In Anti-Vaping Bill

Photo courtesy of Mike Latimer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

House Democrats Block Amendment To Restrict Marijuana Products In Anti-Vaping Bill

Published

on

House Democrats pushed back against a Republican attempt to include a flavored marijuana vaping ban in a broader anti-vaping bill that passed the chamber on Friday, arguing that it doesn’t make sense to prohibit products that are already illegal under federal law.

Instead, several lawmakers argued that Congress should enact separate cannabis reform legislation that could include provisions designed to protect public health and reduce the appeal of marijuana to youth.

The issue first came up during a House Rules Committee hearing on Wednesday, with Rep. Morgan Griffith (R-VA) introducing an amendment to “include a prohibition against flavored marijuana products” such that they would be “treated in the same manner as flavored tobacco products” under the bill.

While the congressman argued that language of the legislation implicitly already provides for such a ban, he said it was important to clarify to send a message to young people that they can’t vape products containing nicotine or THC.

“Let it not be said in 2029 that we had a chance and we felt maybe we were getting to it in 2020,” he said. “Let’s just go ahead and do it. Let’s say you can’t sell flavored marijuana THC vaping products. My amendment makes that clear.”

Watch the conversation below: 

Democratic members said they shared Griffith’s concern about underage use of flavored cannabis vaping products. However, Rep. Ed Perlmutter (D-CO) pushed back and said the proposal is not germane because marijuana remains illegal under federal law and so regulating these products requires separate congressional action.

Earlier in the hearing, he suggested that his House-passed cannabis banking bill—the Secure and Fair Enforcement (SAFE) Banking Act—could serve as a vehicle to address the body’s concerns.

“We have to start addressing it because we have 47 states that now are allowing some level of marijuana use when the statute under the Controlled Substance Act clearly makes it illegal,” the congressman said. “There’s a bill sitting in the Senate called the SAFE Banking Act that may get back here at some point, and we could put some testing and regulatory components on it.”

Watch this exchange below: 

Is a flavored marijuana vaping ban even necessary?

Also during the hearing, Rep. Rob Woodall (R-GA) pressed Rep. Frank Pallone (D-NJ) about the lack of specificity in the bill as it concerns marijuana vaping products. Woodall said he wanted that aspect addressed before he leaves office in nine months.

“It strikes me…more than strange that banana crush [nicotine vaping products] will no longer be available to adults in my district. But banana strawberry cream, which is an illegal [marijuana] product today, will continue to be available at 180 retailers near you,” Woodall said. “I don’t know how I take that message into my high schools and say that we’re going to reduce drug dependency in the months and years ahead.”

Watch the conversation below: 

Pallone said he appreciates Woodall’s concern that flavored vaping products can mislead consumers about what they’re actually putting into their bodies and that he “would tend to think that the same problem would exist” for flavored marijuana products. However, he said there’s a distinction to be made.

“Most people tell me that nicotine is much more toxic and much more dangerous to your health than marijuana so maybe we shouldn’t have restrictions on marijuana at all and maybe we shouldn’t have any restrictions on flavored marijuana because the marijuana doesn’t have the same health problems that nicotine has,” he said. “Maybe I should say, assuming that marijuana is dangerous then maybe the flavored should be. But it’s not as dangerous.”

“The reality is that we know that nicotine is much more dangerous than marijuana so maybe the flavors masking it is not as serious a problem as it would be for nicotine,” he said.

Griffith’s amendment was blocked from floor consideration in a party-line vote of 3-6 by the panel, but the conversation around flavored marijuana products continued on Friday on the House floor.

Rep. Greg Walden (R-OR) brought a poster board showing pictures of flavored cannabis vaping products and lamented that they are not explicitly included in the anti-vaping bill.

“If you want to do something about kids—if you want to do something about lung disease—then we need to do something about marijuana and the oils it gets mixed with that this bill does not address,” he said.

But Rep. Earl Blumenauer (D-OR) pointed out that if Republicans are interested in ensuring that such marijuana products are properly regulated, the substance needs to be removed from the Controlled Substances Act to provide Congress with the means to enact regulations.

Imposing regulations on marijuana while it’s still federally prohibited is “like regulating flavored heroin,” he said. The congressman added that a bill to deschedule marijuana called the Marijuana Opportunity Reinvestment and Expungement (MORE) Act would give lawmakers the tools to protect public health.

“The challenge that we have now is to be able to move forward—to be able to protect young people and the public,” Blumenauer said. “Cannabis is a red herring. If we tax and regulate it, then we can deal with the products they’re talking about. But unless and until we bring it—as two-thirds of the states have done—to actually tax and regulate it, we can’t deal with that. It doesn’t matter.”

Not all Democrats were on board with the anti-vaping bill.

It was a tight 213-195 vote in the House on Friday. Top Democratic leaders are faced challenges as they worked to get the broader legislation approved. Some members of the party have expressed opposition over policies to ban flavored tobacco, including menthol, which they argue would lead to overpolicing of minority communities.

Banning CBD Products Would Be ‘A Fool’s Game,’ FDA Chief Admits

Image by Lindsay Fox from Pixabay.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!